208:
505:
243:
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
759:
719:
498:
776:
386:
491:
390:
613:
411:
212:
764:
26:
415:
8:
216:
803:
237:) can be created by placing the letter Q in front of the human ATC code: for example,
690:
437:
40:
473:
73:
622:
770:
558:
548:
316:
304:
150:
459:
797:
735:
553:
360:
310:
219:
and other medical products. Subgroup M04 is part of the anatomical group
95:
63:
44:
483:
440:. WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018
328:
676:
579:
101:
90:
69:
51:
36:
744:
739:
665:
630:
589:
584:
366:
267:
234:
387:"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis"
714:
698:
656:
640:
635:
574:
543:
528:
347:
341:
335:
298:
290:
279:
273:
230:
220:
190:
185:
180:
175:
170:
165:
160:
155:
145:
140:
135:
130:
125:
120:
22:
730:
594:
322:
258:
256:
288:
670:
661:
599:
83:
725:
55:
59:
515:
476:. WHO Collaborating Centre for Drug Statistics Methodology.
462:. WHO Collaborating Centre for Drug Statistics Methodology.
249:
329:
M04AC Preparations with no effect on uric acid metabolism
105:
Other drugs for disorders of the musculo-skeletal system
416:"Anatomical Therapeutic Chemical (ATC) Classification"
410:
209:
353:
211:, a system of alphanumeric codes developed by the
795:
513:
499:
247:
506:
492:
796:
487:
13:
16:Pharmaceutical drug classification
14:
815:
354:M04AX Other antigout preparations
284:M04AA51 Allopurinol, combinations
207:is a therapeutic subgroup of the
215:(WHO) for the classification of
474:"ATCvet Index 2022: code QM04"
466:
460:"ATC/DDD Index 2022: code M04"
452:
430:
404:
379:
291:increasing uric acid excretion
257:M04AA Preparations inhibiting
1:
391:National Institutes of Health
372:
7:
614:Xanthine oxidase inhibitors
418:. World Health Organization
10:
820:
438:"Structure and principles"
754:
707:
689:
649:
621:
612:
567:
536:
527:
412:World Health Organization
213:World Health Organization
346:M04AC51 Colchicine and
223:Musculo-skeletal system
94:Drugs for treatment of
27:Musculo-skeletal system
205:Antigout preparations
202:ATC code M04
289:M04AB Preparations
781:Never to phase III
691:Mitotic inhibitors
791:
790:
685:
684:
608:
607:
199:
198:
41:Anti-inflammatory
811:
623:purine analogues
619:
618:
534:
533:
508:
501:
494:
485:
484:
478:
477:
470:
464:
463:
456:
450:
449:
447:
445:
434:
428:
427:
425:
423:
408:
402:
401:
399:
397:
383:
74:Muscle relaxants
19:
18:
819:
818:
814:
813:
812:
810:
809:
808:
794:
793:
792:
787:
786:
771:Clinical trials
750:
703:
681:
645:
604:
563:
523:
514:Drugs used for
512:
482:
481:
472:
471:
467:
458:
457:
453:
443:
441:
436:
435:
431:
421:
419:
409:
405:
395:
393:
385:
384:
380:
375:
356:
331:
294:
263:
254:
244:
242:
195:
112:Other ATC codes
17:
12:
11:
5:
817:
807:
806:
789:
788:
785:
784:
783:
782:
779:
768:
762:
756:
755:
752:
751:
749:
748:
742:
733:
728:
717:
711:
709:
705:
704:
702:
701:
695:
693:
687:
686:
683:
682:
680:
679:
674:
668:
659:
653:
651:
647:
646:
644:
643:
638:
633:
627:
625:
616:
610:
609:
606:
605:
603:
602:
597:
592:
587:
582:
577:
571:
569:
565:
564:
562:
561:
559:Isobromindione
556:
551:
549:Sulfinpyrazone
546:
540:
538:
531:
525:
524:
511:
510:
503:
496:
488:
480:
479:
465:
451:
429:
403:
377:
376:
374:
371:
370:
369:
363:
355:
352:
351:
350:
344:
338:
330:
327:
326:
325:
319:
317:Isobromindione
313:
307:
305:Sulfinpyrazone
301:
293:
287:
286:
285:
282:
276:
270:
262:
255:
253:
246:
197:
196:
194:
193:
188:
183:
178:
173:
168:
163:
158:
153:
148:
143:
138:
133:
128:
123:
117:
114:
113:
109:
108:
107:
106:
98:
87:
76:
66:
48:
30:
29:
15:
9:
6:
4:
3:
2:
816:
805:
802:
801:
799:
780:
778:
775:
774:
772:
769:
766:
763:
761:
758:
757:
753:
746:
743:
741:
737:
736:Urate oxidase
734:
732:
729:
727:
724:
721:
718:
716:
713:
712:
710:
706:
700:
697:
696:
694:
692:
688:
678:
675:
672:
669:
667:
663:
660:
658:
655:
654:
652:
648:
642:
639:
637:
634:
632:
629:
628:
626:
624:
620:
617:
615:
611:
601:
598:
596:
593:
591:
588:
586:
583:
581:
578:
576:
573:
572:
570:
566:
560:
557:
555:
554:Benzbromarone
552:
550:
547:
545:
542:
541:
539:
535:
532:
530:
526:
521:
517:
509:
504:
502:
497:
495:
490:
489:
486:
475:
469:
461:
455:
439:
433:
417:
413:
407:
392:
388:
382:
378:
368:
364:
362:
361:Urate oxidase
358:
357:
349:
345:
343:
339:
337:
333:
332:
324:
320:
318:
314:
312:
311:Benzbromarone
308:
306:
302:
300:
296:
295:
292:
283:
281:
277:
275:
271:
269:
265:
264:
260:
251:
245:
240:
236:
232:
227:
225:
224:
218:
214:
210:
206:
203:
192:
189:
187:
184:
182:
179:
177:
174:
172:
169:
167:
164:
162:
159:
157:
154:
152:
149:
147:
144:
142:
139:
137:
134:
132:
129:
127:
124:
122:
119:
118:
116:
115:
111:
110:
104:
103:
99:
97:
96:bone diseases
93:
92:
88:
85:
82:
81:
77:
75:
72:
71:
67:
65:
64:muscular pain
61:
58:products for
57:
54:
53:
49:
46:
45:antirheumatic
42:
39:
38:
34:
33:
32:
31:
28:
24:
21:
20:
722:
677:Topiroxostat
671:Myo-inositol
580:Atorvastatin
519:
468:
454:
442:. Retrieved
432:
420:. Retrieved
406:
394:. Retrieved
381:
252:preparations
238:
235:ATCvet codes
228:
222:
204:
201:
200:
100:
89:
86:preparations
79:
78:
68:
50:
35:
767:from market
745:Pegloticase
740:Rasburicase
666:Phytic acid
631:Allopurinol
590:Guaifenesin
585:Fenofibrate
529:Uricosurics
367:Pegloticase
268:Allopurinol
715:Cinchophen
699:Colchicine
657:Febuxostat
641:Tisopurine
636:Oxypurinol
575:Amlodipine
544:Probenecid
396:1 February
373:References
348:probenecid
342:Cinchophen
336:Colchicine
299:Probenecid
280:Febuxostat
274:Tisopurine
261:production
231:veterinary
229:Codes for
23:ATC code M
804:ATC codes
777:Phase III
765:Withdrawn
731:Sevelamer
662:Inositols
595:Lesinurad
568:secondary
444:3 January
422:3 January
323:Lesinurad
259:uric acid
248:M04A Anti
798:Category
600:Losartan
365:M04AX02
359:M04AX01
340:M04AC02
334:M04AC01
321:M04AB05
315:M04AB04
309:M04AB03
303:M04AB02
297:M04AB01
278:M04AA03
272:M04AA02
266:M04AA01
84:Antigout
47:products
726:aspirin
537:primary
56:Topical
760:WHO-EM
723:except
720:NSAIDs
241:.
708:Other
650:other
233:use (
217:drugs
60:joint
516:gout
446:2022
424:2022
398:2020
250:gout
239:QM04
62:and
43:and
520:M04
102:M09
91:M05
80:M04
70:M03
52:M02
37:M01
800::
773::
414:.
389:.
226:.
221:M
151:QI
25::
747:)
738:(
673:)
664:(
522:)
518:(
507:e
500:t
493:v
448:.
426:.
400:.
191:V
186:S
181:R
176:P
171:N
166:M
161:L
156:J
146:H
141:G
136:D
131:C
126:B
121:A
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.